Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 2
1991 1
1993 2
1994 1
1995 1
1997 1
1998 1
2000 1
2001 2
2002 3
2003 2
2005 1
2006 1
2013 1
2014 1
2019 2
2022 4
2023 3
2024 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3b, Randomized, Double-Blind, Placebo-Controlled Study of Sodium Zirconium Cyclosilicate for Reducing the Incidence of Predialysis Hyperkalemia.
Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S. Fishbane S, et al. Among authors: al shurbaji a. J Am Soc Nephrol. 2019 Sep;30(9):1723-1733. doi: 10.1681/ASN.2019050450. Epub 2019 Jun 14. J Am Soc Nephrol. 2019. PMID: 31201218 Free PMC article. Clinical Trial.
Potassium reduction with sodium zirconium cyclosilicate in patients with heart failure.
Tardif JC, Rouleau J, Chertow GM, Al-Shurbaji A, Lisovskaja V, Gustavson S, Zhao Y, Bouabdallaoui N, Desai AS, Chernyavskiy A, Evsina M, Merkely B, McMurray JJV, Pfeffer MA. Tardif JC, et al. Among authors: al shurbaji a. ESC Heart Fail. 2023 Apr;10(2):1066-1076. doi: 10.1002/ehf2.14268. Epub 2022 Dec 23. ESC Heart Fail. 2023. PMID: 36564955 Free PMC article. Clinical Trial.
Hypokalemia Events With Sodium Zirconium Cyclosilicate and Placebo in Hemodialysis Patients.
Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S. Fishbane S, et al. Among authors: al shurbaji a. Kidney Int Rep. 2022 Jan 28;7(4):908-912. doi: 10.1016/j.ekir.2022.01.1058. eCollection 2022 Apr. Kidney Int Rep. 2022. PMID: 35497779 Free PMC article. No abstract available.
Quantitative pharmacogenetics of nortriptyline: a novel approach.
Kvist EE, Al-Shurbaji A, Dahl ML, Nordin C, Alván G, Ståhle L. Kvist EE, et al. Among authors: al shurbaji a. Clin Pharmacokinet. 2001;40(11):869-77. doi: 10.2165/00003088-200140110-00005. Clin Pharmacokinet. 2001. PMID: 11735606 Clinical Trial.
Potassium responses to sodium zirconium cyclosilicate in hyperkalemic hemodialysis patients: post-hoc analysis of DIALIZE.
Fishbane S, Ford M, Fukagawa M, McCafferty K, Rastogi A, Spinowitz B, Staroselskiy K, Vishnevskiy K, Lisovskaja V, Al-Shurbaji A, Guzman N, Bhandari S. Fishbane S, et al. Among authors: al shurbaji a. BMC Nephrol. 2022 Feb 8;23(1):59. doi: 10.1186/s12882-021-02569-7. BMC Nephrol. 2022. PMID: 35135481 Free PMC article. Clinical Trial.
29 results